This is a Single Ascending Dose Tolerance Study

Status Terminated

Clinical Trial Summary

This is a single rising dose tolerance (Part A) followed by a functional magnetic resonance imaging (Part B)

Clinical Trial Description

The Part A of this study is a parallel design followed in a second part by a cross-over design ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Cognition Disorders

Clinical Trial Details

NCT number	NCT01133574
Study type	Interventional
Source	Abbott
Contact
Status	Terminated
Phase	Phase 1
Start date	February 2010
Completion date	July 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02488720` - Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Recruiting	`NCT03544801` - Renji Cerebral Small Vessel Disease Corhort Study
Recruiting	`NCT02813434` - Cerebral Amyloid Imaging Using Florbetapir (AV-45)	Phase 3
Completed	`NCT00400790` - Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane	N/A
Completed	`NCT00052091` - Therapy for Depressed Elders With Thought Problems	Phase 3
Completed	`NCT00021866` - Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy	N/A
Completed	`NCT00267163` - Brain Imaging and Mental Disorders of Aging Intervention	Phase 4
Not yet recruiting	`NCT04079075` - Multiple Interventions to Prevent Cognitive Decline	N/A
Terminated	`NCT03696082` - A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines	N/A
Completed	`NCT02918539` - Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Active, not recruiting	`NCT01708837` - Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction	Phase 4
Completed	`NCT01290939` - Bevacizumab and Lomustine for Recurrent GBM	Phase 3
Terminated	`NCT00548327` - The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype	Phase 2
Unknown status	`NCT00256425` - Cognitive Rehabilitation of Glioma Patients	Phase 3
Recruiting	`NCT03926351` - High Dose Omega 3 in People at Risk for Dementia	Phase 2
Completed	`NCT02118571` - Schizophrenia Cognition Scale Development	N/A
Completed	`NCT01481961` - Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease	N/A
Completed	`NCT00788918` - Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)	N/A
Completed	`NCT00564902` - The Zeaxanthin and Visual Function Study	N/A
Completed	`NCT00529581` - A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis	Phase 2